Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (201-210 of 430) with videos related to

Pageof 43
Sort By:
Preventing Chronic Disease|February 14, 2020
Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health DepartmentBernadette Jakeman, Stefanie J Logothetis, Melissa H Roberts, et al.
The Prostate|April 19, 2023
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancerIoulia Vardaki, Seda Sabah Özcan, Pedro Fonseca, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
American Journal of Cancer Research|April 1, 2021
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancerYuyan Han, Mutian Zhang, Junfeng Xu, et al.
Urology|February 5, 1999
Aneuploidy index in blood: a potential marker for early onset, androgen response, and metastasis in human prostate cancerM Ozen, V L Hopwood, D A Johnston, et al.
Cancer Treatment Reports|July 1, 1982
Management of pelvic complications of malignant urothelial tumors with combined intra-arterial and iv chemotherapyC J Logothetis, M L Samuels, S Wallace, et al.
The Journal of Urology|January 1, 1993
Surgery following response to interferon-alpha-based therapy for residual renal cell carcinomaA Sella, D A Swanson, J Y Ro, et al.
The American Journal of Medicine|August 1, 1986
Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patientsC J Logothetis, M L Samuels, D E Selig, et al.
Critical Care Medicine|June 1, 1995
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotensionR G Kilbourn, G A Fonseca, O W Griffith, et al.
BJU International|March 9, 2011
Maximizing outcomes in genitourinary cancers across the treatment continuumJohn M Fitzpatrick, Joaquim Bellmunt, Robert Dreicer, et al.
Pageof 43

Showing results (201-210 of 430) with videos related to

Sort By:
Pageof 43
Preventing Chronic Disease|February 14, 2020
Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health DepartmentBernadette Jakeman, Stefanie J Logothetis, Melissa H Roberts, et al.
The Prostate|April 19, 2023
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancerIoulia Vardaki, Seda Sabah Özcan, Pedro Fonseca, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
American Journal of Cancer Research|April 1, 2021
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancerYuyan Han, Mutian Zhang, Junfeng Xu, et al.
Urology|February 5, 1999
Aneuploidy index in blood: a potential marker for early onset, androgen response, and metastasis in human prostate cancerM Ozen, V L Hopwood, D A Johnston, et al.
Cancer Treatment Reports|July 1, 1982
Management of pelvic complications of malignant urothelial tumors with combined intra-arterial and iv chemotherapyC J Logothetis, M L Samuels, S Wallace, et al.
The Journal of Urology|January 1, 1993
Surgery following response to interferon-alpha-based therapy for residual renal cell carcinomaA Sella, D A Swanson, J Y Ro, et al.
The American Journal of Medicine|August 1, 1986
Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patientsC J Logothetis, M L Samuels, D E Selig, et al.
Critical Care Medicine|June 1, 1995
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotensionR G Kilbourn, G A Fonseca, O W Griffith, et al.
BJU International|March 9, 2011
Maximizing outcomes in genitourinary cancers across the treatment continuumJohn M Fitzpatrick, Joaquim Bellmunt, Robert Dreicer, et al.
Pageof 43